| Patents for C07J 1 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, not substituted in position 17 beta by a carbon atom, e.g. oestrane, androstane (4,828) |
|---|
| 06/27/2001 | CN1301165A Medicament for preventing and/or treating a mammary carcinoma, containing a steroidal aromatase inhibitor |
| 06/21/2001 | WO2001044267A1 11-β-PHENYLESTRADIENE DERIVATIVES WITH FLUOROALKYL GROUPS IN THE AROMATIC SIDE CHAIN, PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS |
| 06/21/2001 | WO2000009101A3 Use of estrogenic compounds as anti-fungal agents |
| 06/12/2001 | US6245811 Fatty acid esters as bioactive compounds |
| 06/07/2001 | WO2001040253A2 3-methylene steroid derivative for the treatment of autoimmune diseases |
| 06/07/2001 | CA2391096A1 3-methylene steroid derivatives |
| 05/31/2001 | WO2001037840A1 Methods for treating mild cognitive impairment |
| 05/30/2001 | EP1102582A2 Inhibitors of type 3 3alpha-hydroxysteroid dehydrogenase |
| 05/29/2001 | US6239123 Use of estrogenic compounds as anti-fungal agents |
| 05/25/2001 | WO2001035949A2 Treatment or systemic lupus erythematosus (sle) with dehydroepiandrosterone |
| 05/25/2001 | CA2388705A1 Treatment of sle with dehydroepiandrosterone |
| 05/17/2001 | WO2001035106A2 Methods for identifying and using amyloid-inhibitory compounds |
| 05/17/2001 | DE19954105A1 Treatment of estrogen deficiency-associated conditions, e.g. menopausal syndrome, osteoporosis, infertility or prostatic hypertrophy, using new or known gonatrienes having tissue-selective estrogenic activity |
| 05/17/2001 | CA2390161A1 Methods for identifying and using amyloid-inhibitory compounds |
| 05/16/2001 | EP1099706A2 Estrane sulphamate derivatives as steroid sulphatase inhibitors |
| 05/15/2001 | CA2023008C 4-substituted 17.beta. -(cyclopropyloxy)androst-5-en-3.beta.-ol and related compounds useful as c17-20 lyase inhibitors |
| 05/10/2001 | WO2001032680A2 18-nor-steroids as selectively active estrogens |
| 05/10/2001 | WO2001000652A3 11β LONG-CHAIN SUBSTITUTED ESTRATRIENES, METHOD FOR THEIR PRODUCTION, PHARMACEUTICAL PREPARATIONS CONTAINING SAID 11β LONG-CHAIN SUBSTITUTED ESTRATRIENES, AND THEIR USE FOR PRODUCING MEDICAMENTS |
| 05/10/2001 | US20010001097 Stress-follower circuit configuration |
| 05/09/2001 | CN1294514A Steroid derived antibiotics |
| 05/03/2001 | WO2001030802A2 Therapeutic treatments comprising administration of certain steroids for blood cell deficiencies |
| 05/02/2001 | EP1094798A2 INHIBITORS OF TYPE 5 AND TYPE 3 17beta-HYDROXYSTEROID DEHYDROGENASE AND METHODS FOR THEIR USE |
| 05/01/2001 | CA2001264C 3.beta.,17.beta.-hydroxy-substituted steroids and related steroidal compounds |
| 04/26/2001 | WO2000059447A3 Use of sex hormones to obtain a nasal pharmaceutical composition that is useful in the treatment of undesirable uterine bleeding |
| 04/25/2001 | CN1292702A Newcontraceptive kit for monotherapy |
| 04/24/2001 | CA2061101C Use of tba as a drug against stress in aquaculture |
| 04/19/2001 | WO2001027622A1 Crystallographic structure of the androgen receptor ligand binding domain |
| 04/19/2001 | WO2001027132A1 Estradiol conjugates and uses thereof |
| 04/19/2001 | WO2001026618A2 Composition, especially a cosmetic composition, containing a steroid and a liposoluble uv filter |
| 04/19/2001 | CA2388253A1 Crystallographic structure of the androgen receptor ligand binding domain |
| 04/19/2001 | CA2385096A1 Estradiol conjugates and uses thereof |
| 04/19/2001 | CA2355357A1 Composition, especially a cosmetic composition, containing a steroid and a liposoluble uv filter |
| 04/18/2001 | EP1092423A2 Use of DHEA or its precursors and metabolites as skin depigmentation agents |
| 04/12/2001 | WO2001025469A2 Method for preparing steroids modified by yeast fermentation |
| 04/12/2001 | CA2386419A1 Method for preparing steroids modified by yeast fermentation |
| 04/11/2001 | EP1090027A1 Novel 17-halogenated 19-nor steroids, method and intermediates for preparing same, use as medicines and pharmaceutical compositions containing same |
| 04/11/2001 | CN1291102A Pharmaceutical preparation for selectively supplementing oestrogen deficiency in the central nervous system |
| 04/05/2001 | WO2001023405A2 Therapeutic treatment of androgen receptor driven conditions |
| 04/05/2001 | CA2386095A1 Therapeutic treatment of androgen receptor driven conditions |
| 04/04/2001 | EP1087986A1 7.alpha.-methyl 19-nortestosterone undecanoate with androgenic activity |
| 04/04/2001 | EP0983291A4 Carbamate-derivatized nucleosides and oligonucleosides |
| 04/04/2001 | CN1064048C Five compounds of Qingyang ginseng glucoside and its preparation method and application |
| 03/29/2001 | WO2001021157A2 Local delivery of 17-beta estradiol for preventing vascular intima hyperplasia and for improving vascular endothelium function after vascular injury |
| 03/22/2001 | WO2000032177A3 Use of 17-ketosteroids in the treatment of hepatitis c virus and other togavirus infections |
| 03/21/2001 | EP1083904A2 Pharmaceutical compositions and uses for androst-5-ene-3 beta,17 beta-diol |
| 03/21/2001 | EP0738275B9 Novel antiandrogenic agents and related pharmaceutical compositions and methods of use |
| 03/15/2001 | WO2001018027A1 Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11 |
| 03/15/2001 | WO2001018026A1 Steroids, their preparation, pharmaceutical compositions thereof and uses of the compounds |
| 03/14/2001 | EP1082337A1 17 beta-amino and hydroxylamino-11 beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 03/14/2001 | CN1287123A Steroid and its preparation method, medicine composition and application |
| 03/08/2001 | WO2001016601A1 Effect of steroids on nmda receptors depends on subunit composition |
| 03/08/2001 | CA2383047A1 Effect of steroids on nmda receptors depends on subunit composition |
| 03/07/2001 | EP0650521B1 Determination of estradiol by competitive immunoassay |
| 03/01/2001 | WO2001014406A1 Antiandrogen agents |
| 03/01/2001 | WO2001014405A2 Methods of obtaining 2-methoxyestradiol of high purity |
| 03/01/2001 | CA2376297A1 Methods of obtaining 2-methoxyestradiol of high purity |
| 02/27/2001 | CA2188907C Combination compound for contraception based on natural estrogen |
| 02/22/2001 | WO1999046279A3 INHIBITORS OF TYPE 5 AND TYPE 3 17β-HYDROXYSTEROID DEHYDROGENASE AND METHODS FOR THEIR USE |
| 02/15/2001 | WO2001010430A2 Use of estrogen compounds for prevention and treatment of ischemic damage |
| 02/15/2001 | WO2000059920A3 Orally active 7.alpha.-alkyl androgens |
| 02/15/2001 | CA2348959A1 Methods of cytoprotection using an enantiomer of estrogen of ischemic damage |
| 02/14/2001 | CN1061983C 4-trifluoromethyl-3-ketosteroid compound and synthesizing method thereof |
| 02/13/2001 | US6187767 Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome |
| 02/13/2001 | CA2021501C Topical pharmaceutical compositions |
| 02/07/2001 | CN1283200A Androfenic Steroid compounds and method of making and using the same |
| 01/25/2001 | WO2001005806A1 Orally active androgens |
| 01/25/2001 | WO2001005805A2 Novel c-19-halogen-substituted, 5-substituted, 5-substituted or 6,10 carbocyclically condensed steroids of the androst-9(11)-ene-series, methods for the production and use thereof |
| 01/25/2001 | CA2379223A1 Orally active androgens |
| 01/24/2001 | EP1070704A1 VITAMIN D DERIVATIVES SUBSTITUTED AT THE 2$g(b)-POSITION |
| 01/24/2001 | CN1061052C 11 Beta-aromatic group-4-estraene and acid additive salt application in medicine |
| 01/18/2001 | DE19934088A1 Neue C-19-halogensubstituierte Steroide der Androst-9(11)-en-Reihe, Verfahren zu ihrer Herstellung sowie ihre Verwendung New C-19 halogen-substituted steroids of androst-9 (11) -en-series, processes for their preparation and their use |
| 01/16/2001 | US6174876 Use of boswellic acid for treating brain tumors |
| 01/09/2001 | US6172056 Administering a estrogen compound |
| 01/04/2001 | WO2001000652A2 11β LONG-CHAIN SUBSTITUTED ESTRATRIENES, METHOD FOR THEIR PRODUCTION, PHARMACEUTICAL PREPARATIONS CONTAINING SAID 11β LONG-CHAIN SUBSTITUTED ESTRATRIENES, AND THEIR USE FOR PRODUCING MEDICAMENTS |
| 01/03/2001 | EP1063998A1 Medicament for preventing and/or treating a mammary carcinoma, containing a steroidal aromatase inhibitor |
| 01/03/2001 | EP0735992B1 Method of converting hydroxyl groups into corresponding fluoro compounds |
| 01/02/2001 | US6169082 Salts of 8,9-dehydroestrone sulfate ester |
| 12/28/2000 | DE19929715A1 New 11-beta-long chain substituted estratriene derivatives, are antiestrogens or tissue-selective partial estrogens useful e.g. for treating hormone-dependent cancer or osteoporosis |
| 12/28/2000 | DE10006155A1 One pot preparation of 16alpha(18F)fluoroestradiol sulfamate compounds, useful as markers for estrogen receptor-positive tumors, from 16,17-O-sulfuryl-16-epiestriol derivatives |
| 12/27/2000 | EP1061928A2 New contraceptive kit |
| 12/27/2000 | EP0716604A4 Thiol-derivatized nucleosides and oligonucleosides |
| 12/26/2000 | US6166188 Nucleosides and oligonucleosides functionalized to include carbamate functionality; for the diagnosis of normal or disease states of cells, cellular components or organisms and treatment of diseases through modulation of dna, rna |
| 12/26/2000 | US6166017 Method of using ketoconazole and related substances in medicaments for treatment of type II diabetes and methods of treating same |
| 12/21/2000 | WO2000032201A3 Use of 17-ketosteroids for the treatment of malaria and trypanosomiasis |
| 12/20/2000 | EP1060744A1 Preventives/remedies for osteoporosis |
| 12/20/2000 | EP1059977A2 Recovery of organic solutes from aqueous solutions |
| 12/19/2000 | CA2050291C Combination therapy for the treatment of estrogen sensitive diseases |
| 12/13/2000 | EP1058552A1 Steroid derived antibiotics |
| 12/12/2000 | US6159960 Steroid sulphatase inhibitors |
| 12/07/2000 | WO2000032176A3 Use of 17-ketosteroids for the treatment of toxoplasmosis and cryptosporidosis |
| 12/06/2000 | EP1057809A1 Carbonate derivatives of retinol, process for their preparation and utilisations |
| 12/06/2000 | EP1056692A1 Materials for screening of combinatorial libraries |
| 12/06/2000 | EP1056460A1 Pharmaceutical preparations for selectively supplementing oestrogen deficiency in the central nervous system |
| 12/05/2000 | US6156335 Tolerated, stable, effective, prevents the crystallisation of active ingredient in the matrix, ensures adequate and extended levels of the active ingredient in blood, and has tack and adhesive properties |
| 11/30/2000 | WO2000042989A3 Novel hydrogel isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules |
| 11/28/2000 | US6153606 Memory enhancement by the administration of Δ5-androstene-3β-ol-7,17-dione and 3β esters thereof |
| 11/28/2000 | US6153217 Nanocochleate formulations, process of preparation and method of delivery of pharmaceutical agents |
| 11/21/2000 | US6150349 Methods for treating psychosis associated with glucocorticoid related dysfunction |
| 11/21/2000 | US6150348 Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome |
| 11/09/2000 | WO2000066611A1 Steroid derivatives |